AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 129 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $11,805,000 | -60.1% | 197,272 | -81.3% | 0.12% | -63.8% |
| Q3 2019 | $29,594,000 | -55.6% | 1,053,538 | -40.1% | 0.34% | -49.4% |
| Q2 2019 | $66,632,000 | +5.4% | 1,759,958 | +8.7% | 0.67% | -0.4% |
| Q1 2019 | $63,206,000 | +1754.6% | 1,619,831 | +913.5% | 0.68% | +1306.2% |
| Q4 2018 | $3,408,000 | – | 159,832 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,485,000 | $69,804,000 | 6.41% |
| Versant Venture Management, LLC | 553,916 | $15,559,500,000 | 6.02% |
| Foresite Capital Management III, LLC | 315,331 | $8,858,000 | 3.38% |
| Opaleye Management Inc. | 285,000 | $8,006,000 | 2.90% |
| Redmile Group, LLC | 2,962,655 | $83,221,000 | 2.78% |
| Casdin Capital, LLC | 860,000 | $24,157,400,000 | 2.50% |
| Sofinnova Investments, Inc. | 933,640 | $26,226,000 | 2.37% |
| Eversept Partners, LP | 253,726 | $7,127,163 | 2.21% |
| PFM Health Sciences, LP | 2,315,938 | $65,055,000 | 1.92% |
| Global Endowment Management, LP | 581,488 | $16,334,000 | 1.43% |